Fresenius Medical Care · 5 hours ago
Sr AR Rep
Fresenius Medical Care is a healthcare company seeking a Senior Accounts Receivable Representative to work from home within the United States. The role involves identifying, analyzing, and resolving complex accounts receivable issues while ensuring compliance with company policies and procedures.
BiotechnologyHealth CareMedical Device
Responsibilities
Perform assigned responsibilities in compliance with company policies and procedures; meeting or exceeding goals within company-defined timelines
Complete data entry operations in applicable systems; ensuring data accuracy and integrity
Identify and analyze necessary reports in the resolution of complex issues requiring further investigation; summarizing findings and management
Manage customer accounts through research and correction of complex account issues; serving as a point of contact as necessary
Maintain an audit trail by creating and updating account files throughout the accounts receivable process
Perform administrative activities in support of accounts receivable operations within the assigned function(s)
Mentor other staff as applicable
Assist with various projects as assigned by direct supervisor
Other duties as assigned
Qualification
Required
High School Diploma required
2 - 4 years' related experience
Strong computer skills with demonstrated proficiency in word processing, spreadsheet, database and email applications
Detail oriented with strong analytical and organizational skills
Great time management skills with the ability to multitask concurrent priorities in an organized manner
Must be able to work independently with minimal supervision, and alternately work cohesively within a team environment
Possess a positive, enthusiastic and energetic attitude
Strong oral and written communication skills to effectively communicate with all levels of management
Healthcare AR Experience a Must Have
Preferred
Associate's Degree desirable
Company
Fresenius Medical Care
Fresenius Medical Care is a healthcare company that provides dialysis treatment for those with chronic kidney diseases.
Funding
Current Stage
Public CompanyTotal Funding
$758.43M2025-11-17Post Ipo Debt· $579.5M
2025-07-21Post Ipo Equity· $4.86M
2020-02-25Post Ipo Equity· $6.07M
Leadership Team
Recent News
2025-11-19
2025-11-11
Company data provided by crunchbase